HROW Q4 2021 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$20M+38.3% YoY

Gross Profit

$15M74.8% margin

Operating Income

-$2M-8.7% margin

Net Income

-$7M-36.7% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+7.9%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$28M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$98M

Total Liabilities

$87M

Stockholders' Equity

$11M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$15M	+38.3%
Gross Profit	$15M	$11M	+41.8%
Operating Income	-$2M	$3M	-166.8%
Net Income	-$7M	$1M	-745.6%

Revenue Segments

Other Revenues

$1M100%